Form 8-K - Current report:
SEC Accession No. 0001564590-17-003867
Filing Date
2017-03-09
Accepted
2017-03-09 16:46:05
Documents
3
Period of Report
2017-03-09
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K FILING SEDAR NOTICE OF AGM xene-8k_20170309.htm 8-K 29883
2 EX-99.1 xene-ex991_14.htm EX-99.1 14884
3 GRAPHIC g2017030916461160030277.jpg GRAPHIC 12220
  Complete submission text file 0001564590-17-003867.txt   62833
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Filer) CIK: 0001582313 (see all company filings)

EIN.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36687 | Film No.: 17679035
SIC: 2834 Pharmaceutical Preparations